scholarly journals Pharmaceutical Care Network Europe (PCNE) Drug-Related Problems Classification Version 9.1: First Implementation in Sudan

2021 ◽  
pp. 699-706
Author(s):  
Kannan O. Ahmed ◽  
Hiba F. Muddather ◽  
Bashir A. Yousef
Keyword(s):  
Pharmaceutical Care ◽  
Outcome Measure ◽  
Hospital Setting ◽  
Routine Care ◽  
Care Work ◽  
Drug Event ◽  
Drug Related Problems ◽  
Care Network ◽  
Clinical Pharmacists ◽  
Routine Work

Background: Clinical pharmacy services are an emerging specialty in Sudan. Many tools exist to document drug-related problems (DRP), such as the Pharmaceutical Care Network Europe (PCNE) classification. However, none has been attempted and published in Sudan. Objectives: The study aimed to identify the DRP and its characteristics in real hospital setting using non-modified version of PCNE. Method: Prospective study of clinical pharmacists' interventions during the routine care work of reviewing patients over a period from December 2020 to February 2021 at the wards of National Cancer Institute, University of Gezira, Sudan. Main outcome measure Using non-modified PCNE version 9.1 to identify the number, types, causes of the DRP, clinical pharmacists' interventions, acceptance, and outcomes. Results: Five minutes (range, 3-15 minutes) was the median time spent for evaluation and intervention by the clinical pharmacists, a total of 51 DRP were discovered among 40 patients with an average of 1.3 DRP per patient, an adverse drug event (possibly) occurring (29.4%) was the main problem, no or incomplete drug treatment (27.5%) was the main causes, above one-third of the clinical pharmacists' interventions were proposed to the prescriber, these interventions were accepted in 96% and fully implemented among 72.5% of the cases. At the end of the process, the majority of DRP (72.5%) were totally solved. Conclusion: Non-modified PCNE version 9.1 provides a suitable tool for the DRP process for Sudanese clinical pharmacists during routine work in the oncology setting. It hence can be considered as an optimal tool for further quality and policymaking.

A simulation study of the interception of prescribing errors by clinical pharmacists in an acute hospital setting

2015 ◽  
Vol 21 (4) ◽  
pp. 673-680 ◽  
Author(s):  
Thibaut Caruba ◽  
Abdelali Boussadi ◽  
Emilie Lenain ◽  
Virginie Korb-Savoldelli ◽  
Florence Gillaizeau ◽  
...  
Keyword(s):  
Simulation Study ◽  
Hospital Setting ◽  
Acute Hospital ◽  
Prescribing Errors ◽  
Clinical Pharmacists ◽  
Acute Hospital Setting

scholarly journals ANALISIS PELAYANAN KEFARMASIAN DI PUSKESMAS TOSIBA KABUPATEN KOLAKA

2018 ◽  
Author(s):  
Musdalipah
Keyword(s):  
Pharmaceutical Care ◽  
Research Method ◽  
Narrative Form ◽  
Drug Related Problems ◽  
The Public ◽  
Descriptive Method

Pharmaceutical care is an activity that aims to identify, prevent and solve drug related problems. The demands of patients and the public on the improvement of the quality of pharmaceutical care, require that the extension of the old paradigma wich oriented to the product (drug oriented) into a patient oriented (patient oriented) with the philosophy of pharmaceutical care. The purpose of this study is to find out the pharmaceutical care in puskesmas tosiba kolaka district. This type of research is done by descriptive method. Research method used is descriptive with retrospektive data retriveal. The sample in this study consisted of the head of tosiba puskesmas, pharmacist and assistent pharmacist. Data are analyzed descriptively and elaborated in narrative form. The results showed that the management of drugs and prescription assessment at puskesmas tosiba kolaka accordance with the standard of pharmaceutical care but facilities and infrastructure that has not been sufficient and also exposed to several other factors.

scholarly journals Identification and solution of drug-related problems in the neurology unit of a tertiary hospital in China

2021 ◽  
Vol 22 (1) ◽  
Author(s):  
Pengpeng Liu ◽  
Guangyao Li ◽  
Mei Han ◽  
Chao Zhang
Keyword(s):  
Tertiary Care ◽  
Patient Treatment ◽  
Major Type ◽  
Drug Related Problems ◽  
Dose Selection ◽  
Nasogastric Feeding ◽  
Factors Associated ◽  
Clinical Pharmacists ◽  
Medication Therapy ◽  
Medication Error Reporting

Abstract Background The prevalence and characteristics of drug-related problems (DRPs) and factors associated with the occurrence of DRPs in the neurology unit in China remain unknown. This study aimed to determine the prevalence, characteristics and severity ratings of DRPs and identify factors associated with the occurrence of DRPs in the neurology unit of a tertiary care and academic teaching hospital in China. Methods A retrospective study of DRPs and pharmacists’ interventions for neurology patients was performed during a non-consecutive 24-month study period. Patient demographics and clinical characteristics, and pharmacist’s intervention records were collected. The characteristics and severity ratings of DRPs were categorized using the Pharmaceutical Care Network Europe (PCNE) DRP classification tool V9.00 and the National Coordinating Council for Medication Error Reporting and Prevention (NCC-MERP) classification respectively. Results A total of 242 DRPs were detected for 974 admitted patients, an average of 0.25 DRPs per patient. Treatment safety was the major type of DRPs (106;43.8%) followed by treatment effectiveness (78;32.2%). The primary causes of DRPs were drug selection (124;44.1%) and dose selection (92;32.7%). Clinical pharmacists provided 525 interventions, and most interventions occurred at the prescriber level (241;45.9%). A total of 91.4% of these interventions were accepted, contributing to solving 93.0% of the identified problems. The majority of DRPs (210;86.8%) were rated at severity categories B to D (causing no patient harm). Multiple logistic regression showed that creatinine clearance, number of medications used, nasogastric feeding, diabetes, and infectious diseases were associated with more frequent DRPs (p < 0.05). Conclusions DRPs are relatively common in the neurology unit in China, with primary causes of drug and dose selection, and clinical pharmacists can effectively reduce and prevent DRPs to optimize medication therapy.

scholarly journals Pharmaceutical care in a school pharmacy: from consultation to resolution of drug-related problems

2019 ◽  
Vol 41 (1) ◽  
pp. 42470
Author(s):  
Amanda Thiemy Chiozzi Watanabe ◽  
Fernando Henrique Zonzini ◽  
Maurício Fumio Sybui ◽  
Angela Maria Campanha
Keyword(s):  
Pharmaceutical Care ◽  
Anatomical Therapeutic Chemical ◽  
Descriptive Analysis ◽  
State University ◽  
Drug Related Problems ◽  
Relevant Role ◽  
Professional Information ◽  
General Community

This study aimed to provide pharmaceutical care for the general community served by Pharmacy students from the Pharmacy School of the State University of Maringá [Universidade Estadual do Maringá] (UEM). Pharmacotherapeutic follow-up was performed with the identification, classification and resolution of drug-related problems (DRPs) through pharmaceutical consultations. A descriptive analysis was conducted. A total of 59 patients were interviewed; they were mostly women (75%) with average age of 63 years, and each of them was taking 8 medicines on average. The most frequently mentioned drugs were classified according to the Anatomical Therapeutic Chemical Code and related to cardiovascular system (28%), alimentary tract and metabolism (23%), and nervous system (20%). An average of 1.49 DRP per patient was detected (88), and treatment non-compliance was the most frequent DRPs found (45%). In view of this, 63 pharmaceutical interventions were carried out, with most of them (52%) being related to patient education on the treatment; approximately 20% of the patients were referred to another health professional. Information supplied by this study shows the relevant role of pharmacists face the lack of pharmacotherapeutic follow-up of polymedicated patients.

scholarly journals GRANDPARENTING CHILDREN WITH DISABILITIES AND ITS IMPACT ON GRANDPARENT HEALTH

2019 ◽  
Vol 3 (Supplement_1) ◽  
pp. S628-S628
Author(s):  
Ynesse Abdul-Malak ◽  
Madonna Harrington Meyer
Keyword(s):  
Children With Disabilities ◽  
Routine Care ◽  
Life Course Perspective ◽  
Care Work ◽  
Negative Effects ◽  
Public Programs ◽  
Feeding Tubes ◽  
The Us ◽  
The Impact ◽  
Depth Interviews

Abstract Across the US, millions of grandparents are providing vital care for their grandchildren with disabilities when their adult children are in need of assistance and public programs do not provide needed supports. Research suggests the impact on grandparent physical health is mixed. This paper draws on in-depth interviews with 50 grandparents to explore how caring for grandchildren with disabilities shapes their physical wellbeing. We use life course perspective to assess the choices grandparents make from available resources and options at different stages of their lives and the effects on their health. We find in addition to providing routine care, helping with feeding, bathing, and dressing, some grandparents provide constant supervision and medically intense care, such as tending to feeding tubes, catheters, and oxygen lines. Many grandparents said care work has improved, or at least helped sustain, their overall level of fitness, while other grandparents find that care work has adverse impacts. Often there is too much chasing, bending, and lifting for their aging bodies. This paper suggests that stronger social programs for children with disabilities and the grandparents who step in to help them would decrease the negative effects of care work on grandparent health.

scholarly journals Pharmaceutical Care in Sports

Pharmacy ◽  
2020 ◽  
Vol 8 (4) ◽  
pp. 218
Author(s):  
José Henrique Gialongo Gonçales Bomfim
Keyword(s):  
Physical Activity ◽  
Adverse Events ◽  
Pharmaceutical Care ◽  
Herbal Drugs ◽  
Clinical Services ◽  
Drug Related Problems ◽  
Health Team ◽  
As Doping

Pharmaceutical care in sports is a new field of work to clinical pharmacists, focused on promoting pharmacotherapeutic follow up and clinical services to athletes, physical activity practitioners and enthusiasts of any sports modality. A broad range of pharmaceuticals, dietary supplements and herbal drugs have been used historically as performance promoters, doping or ergogenic aids. In this context, the role of pharmacists in prevent adverse events, drug interactions or any drug related problems, as doping issues, was described. Its actions can be important to contribute with a multi professional clinical health team, leading athletes to use these resources in a rational way, promoting and optimizing the therapeutic when its necessary.

Drug-related problems with targeted/immunotherapies at an oncology outpatient clinic

2019 ◽  
Vol 26 (3) ◽  
pp. 595-602
Author(s):  
Esra Kucuk ◽  
Aygin Bayraktar-Ekincioglu ◽  
Mustafa Erman ◽  
Saadettin Kilickap
Keyword(s):  
Adverse Drug Event ◽  
Clinical Pharmacist ◽  
Adverse Drug Events ◽  
Drug Event ◽  
Targeted Chemotherapy ◽  
Drug Related Problems ◽  
Patients With Cancer ◽  
Common Drug ◽  
Oncology Care ◽  
The Impact

Background Some studies in the literature describe drug-related problems in patients with cancer, although few studies focused on patients receiving targeted chemotherapy and/or immunotherapy. To identify the incidence of drug-related problems in patients receiving targeted chemotherapy and/or immunotherapy, and demonstrate the impact of a clinical pharmacist in an outpatient oncology care setting. Methods Prospective study was conducted in a hospital outpatient oncology clinic between October 2015 and March 2016. Patients greater than 18 years old receiving cetuximab, nivolumab, ipilimumab, or pembrolizumab were included in the study and monitored over a three-month period by a clinical pharmacist. Drug-related problems were analyzed using the Pharmaceutical Care Network Europe classification system. The main outcome measures were the frequency and causes of drug-related problems and the degree of resolution achieved through the involvement of a clinical pharmacist. Results A total of 54 patients (mean age: 57 ± 12 years) were included. There were 105 drug-related problems and 159 associated causes. Among the planned interventions (n = 149), 92 interventions were at the patient-level with 88 (96%) being accepted by the doctors. This resulted in 68 (65%) drug-related problems being completely resolved and 9 (8.6%) being partially resolved. The most common drug-related problem identified was “adverse drug event” (n = 38, 36%). Of the 105 drug-related problems, 63 (60%) related to targeted chemotherapy and/or immunotherapy with 34 (54%) classified as an “adverse drug event.” Conclusion Adverse drug events were the most common drug-related problems in patients with cancer. The involvement of a clinical pharmacist improved the identification of drug-related problems and helped optimize treatment outcomes in patients receiving targeted chemotherapy/immunotherapy.

Sign in / Sign up

Export Citation Format

Share Document